Irreversible Electroporation (IRE) for Prostate Cancer (PCa) Treatment: The State of the Art
We evaluated the most recent research from 2000 to 2023 in order to deeply investigate the applications of PCa IRE, first exploring its usage with primary intent and then salvage intent. Finally, we discuss the differences with other focal PCa treatments. In the case of primary-intent IRE, the in-fi...
Main Authors: | Eliodoro Faiella, Domiziana Santucci, Daniele Vertulli, Elva Vergantino, Federica Vaccarino, Gloria Perillo, Bruno Beomonte Zobel, Rosario Francesco Grasso |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-01-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/14/2/137 |
Similar Items
-
An overview of the irreversible electroporation for the treatment of liver metastases: When to use it
by: Maria Paola Belfiore, et al.
Published: (2022-09-01) -
Sequential Irreversible Electroporation for Locally Advanced Pancreatic Cancer
by: Daniel Yuxuan Ong, et al.
Published: (2023-11-01) -
Focal Minimally Invasive Treatment in Localized Prostate Cancer: Comprehensive Review of Different Possible Strategies
by: Eliodoro Faiella, et al.
Published: (2024-02-01) -
Is irreversible electroporation (IRE) an effective and safe ablation method for local advanced pancreatic cancer: A meta-analysis
by: He Shuiqing, et al.
Published: (2022-06-01) -
Stereotactically-navigated percutaneous Irreversible Electroporation (IRE) compared to conventional IRE: a prospective trial
by: Lukas P. Beyer, et al.
Published: (2016-08-01)